IRIS UniCatt

Chiusolo, Patrizia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.306
EU - Europa 7.083
AS - Asia 3.514
SA - Sud America 731
OC - Oceania 164
AF - Africa 129
Continente sconosciuto - Info sul continente non disponibili 7
Totale 18.934
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.128
DE - Germania 2.267
CN - Cina 1.258
SG - Singapore 1.199
IT - Italia 1.116
SE - Svezia 1.102
BR - Brasile 647
FR - Francia 488
GB - Regno Unito 404
UA - Ucraina 392
IE - Irlanda 322
IN - India 287
ID - Indonesia 244
FI - Finlandia 199
RU - Federazione Russa 160
PL - Polonia 151
AU - Australia 144
CA - Canada 129
KR - Corea 99
NL - Olanda 91
TR - Turchia 81
AT - Austria 61
CI - Costa d'Avorio 55
BE - Belgio 51
HK - Hong Kong 51
ES - Italia 39
VN - Vietnam 36
JP - Giappone 35
CZ - Repubblica Ceca 31
IR - Iran 31
MX - Messico 30
AR - Argentina 27
CH - Svizzera 24
RO - Romania 24
BD - Bangladesh 20
NZ - Nuova Zelanda 20
HU - Ungheria 18
SA - Arabia Saudita 17
ZA - Sudafrica 15
IL - Israele 14
LT - Lituania 14
MA - Marocco 14
PT - Portogallo 14
TH - Thailandia 14
CL - Cile 13
EG - Egitto 13
UZ - Uzbekistan 13
AE - Emirati Arabi Uniti 12
CO - Colombia 12
IQ - Iraq 12
DZ - Algeria 11
NO - Norvegia 11
SK - Slovacchia (Repubblica Slovacca) 11
BG - Bulgaria 10
EC - Ecuador 10
GR - Grecia 10
NP - Nepal 10
EE - Estonia 9
PK - Pakistan 9
HR - Croazia 8
LV - Lettonia 8
TW - Taiwan 8
BA - Bosnia-Erzegovina 7
DK - Danimarca 7
KG - Kirghizistan 7
RS - Serbia 7
VE - Venezuela 7
AM - Armenia 6
AZ - Azerbaigian 6
GE - Georgia 6
JO - Giordania 6
PE - Perù 6
PH - Filippine 6
LB - Libano 5
MY - Malesia 5
PA - Panama 5
PY - Paraguay 5
BY - Bielorussia 4
BZ - Belize 4
EU - Europa 4
KE - Kenya 4
MD - Moldavia 4
SC - Seychelles 4
TN - Tunisia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
GH - Ghana 3
IS - Islanda 3
LK - Sri Lanka 3
ME - Montenegro 3
MK - Macedonia 3
QA - Qatar 3
SI - Slovenia 3
UY - Uruguay 3
AL - Albania 2
BH - Bahrain 2
CR - Costa Rica 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
Totale 18.915
Salva come PNG Salva come JPEG
Città #
Chandler 1.057
Singapore 726
Ashburn 489
Dublin 314
Jacksonville 296
Dearborn 243
Jakarta 228
San Mateo 228
Milan 205
Nanjing 178
Rome 170
Ann Arbor 169
Houston 169
Wilmington 161
Los Angeles 158
Beijing 152
Hyderabad 134
Munich 130
Boston 123
New York 122
Woodbridge 116
Warsaw 115
Nürnberg 114
Fairfield 113
Hefei 112
Moscow 110
Frankfurt am Main 108
Seattle 108
Redwood City 106
Lancaster 94
Seoul 92
Cattolica 89
Nanchang 84
Princeton 82
Marseille 81
Chicago 73
Bremen 71
The Dalles 70
Lawrence 68
Helsinki 62
Florence 56
Abidjan 55
Redmond 53
Izmir 50
São Paulo 48
Boardman 47
Brussels 47
Kunming 46
Nuremberg 46
Hong Kong 42
Shanghai 42
London 39
Guangzhou 35
San Francisco 35
Tianjin 35
Toronto 35
Cambridge 33
Shenyang 33
Norwalk 32
Sydney 31
Pune 29
Santa Clara 29
Vienna 29
Düsseldorf 28
Hangzhou 28
Leawood 28
Phoenix 28
Brooklyn 27
Changsha 27
Melbourne 27
Mountain View 26
Zhengzhou 26
Belo Horizonte 25
Portland 25
Brisbane 24
Hebei 23
Lappeenranta 23
Portsmouth 23
Turku 23
Washington 23
Adelaide 22
Auburn Hills 22
Brno 22
Jiaxing 22
Philadelphia 21
Buffalo 19
Hanoi 19
Lauterbourg 19
Rio de Janeiro 19
Wroclaw 18
Augusta 17
Amsterdam 16
Bexley 16
San Diego 16
University Park 16
Naples 15
Tokyo 15
Bologna 14
Columbus 14
Porto Alegre 14
Totale 9.037
Salva come PNG Salva come JPEG
Nome #
VITAMIN B12 DEFICIENCY: CORRELATION BETWEEN MTHFR POLYMORPHISMS AND CLINICAL AND LABORATORY FINDINGS 2.624
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS 377
Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: An open-label, multicentre, randomised, phase 3 trial 326
Reliability of leukostasis grading score to identify patients with high-risk hyperleukocytosis 325
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 245
Salivary proteomic analysis and acute graft versus host disease after allogeneic hematopoietic stem cell transplantation 181
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome 168
Severe veno-occlusive disease after autologous peripheral blood stem cell transplantation for high-grade non-Hodgkin lymphoma: report of a successfully managed case and a literature review of veno-occlusive disease. 167
Correlation between paraproteinaemia and viral reactivation after allo-SCT 156
MTHFR polymorphysms in myelodysplastic syndromes and therapy-related myeloid neoplasms 151
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation. 149
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 143
Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia 143
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 142
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 141
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation 139
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 138
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 138
The role of HLA--G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis 136
Prognostic implications of additional genomic lesions in adult Philadelphia chromosome-positive acute lymphoblastic leukemia 136
Prospective evaluation of Epstein-Barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 133
Chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab. 131
Highly active antiretroviral therapy and allogeneic CD34(+) peripheral blood progenitor cells transplantation in an HIV/HCV coinfected patient with acute myeloid leukemia 130
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 129
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 128
Low-dose valganciclovir as preemptive therapy for cytomegalovirus infection occurring in allogeneic stem cell transplant recipients 128
Low incidence of secondary neoplasia after autotransplantation for lymphoproliferative disease: the role of pre-transplant therapy 127
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 125
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication 120
EXTREME THROMBOCYTOSIS IN CHRONIC MYELOID LEUKEMIA IN THE ERA OF TYROSINE KINASE INHIBITORS 119
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 118
Work related acute leukemia and mucor mycosis in a boat-builder 117
Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response duration 117
Allogeneic cord blood transfusions prevent fetal haemoglobin depletion in preterm neonates. Results of the CB-TrIP study 116
Bone marrow megakaryocytic activation predicts fibrotic evolution of Philadelphia-negative myeloproliferative neoplasms 116
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation 115
Role of 18F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients. 114
Prevalence of the JAK2 V617F mutation in patients with unprovoked venous thromboembolism of common sites and without overt myeloproliferative neoplasms 113
AB0 type does not affect platelet engraftment after autologous peripheral blood stem cell transplant in a series of 249 hematologic patients 113
Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia 113
Prospective evaluation of epstein-barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 111
Hyperleukocytosis and leukostasis: management of a medical emergency 111
Hyperleukocytosis and leukostasis: management of a medical emergency 110
Retrospective comparison of qualitative and quantitative reverse transcriptase polymerase chain reaction in diagnosing and monitoring the ALL1-AF4 fusion transcript in patients with acute lymphoblastic leukaemia. 109
The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue 109
Role of fecal calprotectin as biomarker of gastrointestinal GVHD after allogeneic stem cell transplantation 109
Neurologic improvement after peripheral blood stem cell transplantation in poems 109
Role of (18)F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients 109
Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms 108
H1N1 Influenza among Hematological Patients: Monocentric Influenza Cases from 2011 to 2016 108
. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. 106
JAK2 V617F mutational frequency in essential thrombocythemia associated with splanchnic or cerebral vein thrombosis 105
Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience 104
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 103
MTHFR polymorphisms involved in vitamin B12 deficiency associated with atrophic gastritis 101
High-dose glucocorticoids plus Ofatumumab in fludarabine/alemtuzumab-resistant B-cell chronic lymphocytic leukemia 99
Granulocyte transfusions as adjunctive treatment of invasive fungal diseases in neutropenic patients 99
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 99
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 99
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT 99
Hyperhomocysteinemia and prevalence of polymorphisms of homocysteine metabolism-related enzymes in patients with inflammatory bowel disease 98
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 95
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 94
Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population 93
Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial 93
Non-tunnelled central venous catheters in adult stem cell transplantation recipients: an effective option 92
Inline and offline extracorporeal photopheresis: Device performance, cell yields and clinical response 88
Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience 87
Fecal but not serum calprotectin is a potential marker of GVHD after stem cell transplantation. 86
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T 85
Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy 84
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 84
Negative prognostic value of glutathione s-transferase (gstm1 and gstt1) deletions in adult acute myeloid leukemia. 82
UGT1A1 Polymorphism and Mortality Outcome after Allogeneic Stem Cell Transplantation with Busulfan Based Regimen 82
Changes in protein serum levels during stem cell transplantation 81
Peripheral Blood Hemopoietic Stem Cell Mobilization Regimens in POEMS Syndrome: A Retrospective Study at 2 Hematologic Italian Centers 81
Coronavirus disease 2019 pandemic and allogeneic hematopoietic stem cell transplantation: a single center reappraisal 81
Reduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid 79
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 79
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 79
Extracorporeal Photopheresis for Treatment of Acute and Chronic Graft Versus Host Disease: An Italian Multicentric Retrospective Analysis on 94 Patients on Behalf of the Gruppo Italiano Trapianto di Midollo Osseo 78
Allogeneic Hemopoietic Stem Cell Transplants in Patients with Acute Myeloid Leukemia (AML) Prepared with Busulfan and Fludarabine (BUFLU) or Thiotepa, Busulfan, and Fludarabine (TBF): A Retrospective Study 78
Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients 78
Extramedullary Involvement in Acute Myeloid Leukemia. A Single Center Ten Years' Experience 78
Incidence and Outcome of Invasive Fungal Diseases after Allogeneic Stem Cell Transplantation: A Prospective Study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO) 77
Unrelated cord blood transplantation and post-transplant cyclophosphamide 77
SARS CoV 2 infection in chronic myelogenous leukemia: Severe hematological presentation 77
Bone marrow haploidentical transplant with post-transplantation cyclophosphamide :does graft cell content have an impact on main clinical outcomes? 76
ABO Mismatch in Allogeneic Hematopoietic Stem Cell Transplant: Effect on Short- And Long-term Outcomes 76
Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia 75
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 74
Pre-Exposure to Defibrotide Prevents Endothelial Cell Activation by Lipopolysaccharide: An Ingenuity Pathway Analysis 73
Eltrombopag for the treatment of poor graft function following allogeneic stem cell transplant: a retrospective multicenter study 72
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 71
Extracorporeal Photopheresis for Treatment of Acute and Chronic Graft Versus Host Disease: An Italian Multicentric Retrospective Analysis on 94 Patients on Behalf of the Gruppo Italiano Trapianto di Midollo Osseo 71
Triple post transplant cyclophosphamide (PTCY) based GVHD prophylaxis: HLA matched versus HLA haploidentical transplants. 71
Allogeneic hematopoietic stem cell transplantation in therapy-related myeloid neoplasms (t-MN) of the adult: Monocentric observational study and review of the literature 70
Mononuclear cell collection for extracorporeal photopheresis: Concentrate characteristics for off-line UV-A irradiation procedure 69
Bone marrow haploidentical transplant with post-transplantation cyclophosphamide: does graft cell content have an impact on main clinical outcomes? 69
Unselected donor-derived hematopoietic stem cells boost for Chimeric Antigen Receptor T-cell associated hematotoxicity 68
Totale 13.855
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.308
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.308
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020119 0 0 0 0 0 0 0 0 0 0 0 119
2020/20211.254 81 116 81 96 111 101 114 32 152 60 266 44
2021/20221.551 150 91 43 70 104 39 35 221 90 127 261 320
2022/20233.215 436 436 243 476 226 378 182 241 316 89 134 58
2023/20242.681 84 452 125 172 150 302 162 115 105 266 367 381
2024/20255.486 358 271 446 286 462 205 266 254 698 641 1.096 503
Totale 19.297